Nuvation Bio Inc. (NUVB) News
Filter NUVB News Items
NUVB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest NUVB News From Around the Web
Below are the latest news stories about NUVATION BIO INC that investors may wish to consider to help them evaluate NUVB as an investment opportunity.
Companies Like Nuvation Bio (NYSE:NUVB) Are In A Position To Invest In GrowthEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
Nuvation Bio Announces Departure of Chief Financial OfficerNEW YORK, November 13, 2023--Nuvation Bio Inc. (NYSE: NUVB) (the "Company") announced today that Jennifer Fox will be stepping down from her role as Chief Financial Officer to pursue a new opportunity. Ms. Fox has advised the Company that she is seeking later stage development and commercial launch experience as part of her career development and that she is leaving with a high regard for the Company, its leadership and its financial state. Ms. Fox submitted her resignation on November 9, 2023 w |
Nuvation Bio Inc (NUVB) Reports Q3 2023 Financial ResultsCompany's cash and marketable securities stand at $619.3 million as of Q3 2023, with a net loss of $19.6 million |
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNEW YORK, November 02, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the third quarter ended September 30, 2023, and provided a business update. |
One Nuvation Bio Insider Raised Their Stake In The Previous YearInsiders were net buyers of Nuvation Bio Inc.'s ( NYSE:NUVB ) stock during the past year. That is, insiders bought more... |
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateNEW YORK, August 03, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the second quarter ended June 30, 2023, and provided a business update. |
15 Best Penny Stocks To Buy NowIn this article, we will take a look at the 15 best penny stocks to buy now. To see more such companies, go directly to 5 Best Penny Stocks To Buy Now. Investing in penny stocks is risky but if executed correctly gives investors huge opportunities and exposure to multi-baggers of the future. In his […] |
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory BoardNEW YORK, June 01, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the formation of a Scientific Advisory Board. The Scientific Advisory Board will work alongside the Nuvation Bio management team to advance its pipeline of therapeutic candidates for some of the most difficult-to-treat cancers. |
Nuvation Bio Insider Ups Holding During Year \Viewing insider transactions for Nuvation Bio Inc.'s ( NYSE:NUVB ) over the last year, we see that insiders were net... |
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business UpdateNEW YORK, May 04, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the first quarter ended March 31, 2023, and provided a business update. |